Skip to main content
OpenTrials

Clinical trial condition

Iron Deficiency Anemia

Explore clinical trials studying Iron Deficiency Anemia. Study availability and eligibility vary by location and protocol.

170 public trials 13 recruiting studies
Refine in advanced search Browse all conditions

Iron Deficiency Anemia trial results

Completed

Iron Isomaltoside/Ferric Derisomaltose vs Iron Sucrose for Treatment of Iron Deficiency Anemia in Non-Dialysis-Dependent Chronic Kidney Disease

NCT02940860

Conditions
Anemia, Anemia, Hypochromic, Anemia, Iron-Deficiency, +21 more
Locations
  • Pharmacosmos Investigational Site Huntsville, Alabama, United States
  • Pharmacosmos Investigational Site Little Rock, Arkansas, United States
  • Pharmacosmos Investigational Site Little Rock, Arkansas, United States
  • Pharmacosmos Investigational Site Chula Vista, California, United States
View all 141 locations
View Trial Details
Completed

An Extension Trial to Assess the Safety of Re-dosing of Iron Isomaltoside/Ferric Derisomaltose (Monofer®/Monoferric®)

NCT02962648

Conditions
Anemia, Anemia, Hypochromic, Anemia, Iron-Deficiency, +20 more
Locations
  • Pharmacosmos Investigational Site Chula Vista, California, United States
  • Pharmacosmos Investigational Site 1 La Mesa, California, United States
  • Pharmacosmos Investigational Site 2 La Mesa, California, United States
  • Pharmacosmos Investigational Site Northridge, California, United States
View all 22 locations
View Trial Details
Completed

Incidence of Hypophosphatemia After Treatment With Iron Isomaltoside/Ferric Derisomaltose or Ferric Carboxymaltose in Subjects With Iron Deficiency Anaemia

NCT03237065

Conditions
Anemia, Anemia, Hypochromic, Anemia, Iron-Deficiency, +10 more
Locations
  • Pharmacosmos Investigational Site Muscle Shoals, Alabama, United States
  • Pharmacosmos Investigational Site Doral, Florida, United States
  • Pharmacosmos Investigational Site Miami, Florida, United States
  • Pharmacosmos Investigational Site Miami, Florida, United States
View all 15 locations
View Trial Details
Completed

Incidence of Hypophosphatemia After Treatment With Iron Isomaltoside/Ferric Derisomaltose vs Ferric Carboxymaltose in Subjects With Iron Deficiency Anaemia

NCT03238911

Conditions
Anemia, Anemia, Hypochromic, Anemia, Iron-Deficiency, +10 more
Locations
  • Pharmacosmos Investigational Site Los Angeles, California, United States
  • Pharmacosmos Investigational Site Sacramento, California, United States
  • Pharmacosmos Investigational Site Santa Ana, California, United States
  • Pharmacosmos Investigational Site Clearwater, Florida, United States
View all 16 locations
View Trial Details

Related conditions